Vanguard Global Advisers’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.12M Buy
10,841
+3,875
+56% +$227K ﹤0.01% 1685
2026
Q1
$266K Buy
+6,966
New +$220K ﹤0.01% 2302

Other funds holding ATEX

Vanguard Global Advisers's ATEX Position: Q2 2026 in Review

Vanguard Global Advisers increased its Anterix (ATEX) stake by 56% in Q2 2026, buying an estimated $227K and bringing the position to 10,841 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #1685.

Vanguard Global Advisers first reported a position in ATEX in Q1 2026 and has held it in 2 quarters since. 171 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.

  • Vanguard Global Advisers held 10,841 shares of Anterix worth $1.12M as of Q2 2026.
  • Vanguard Global Advisers bought 3,875 Anterix shares in Q2 2026, an estimated $227K.
  • Anterix made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #1685 holding.
  • Vanguard Global Advisers first reported a position in Anterix in Q1 2026 and has held it in 2 quarters since.
  • 171 funds tracked by Wall St. Rank held Anterix as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.